| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 154.12 | 10.9% | 10.8% |
| Total Income | 155.35 | 11.4% | 9.9% |
| Expenditure | 147.87 | 12.5% | 15.6% |
| PBT | 7.48 | 5.7% | 44.3% |
| Net Profit | 5.20 | 13.9% | 38.3% |
| OPM | 7.34% | 1.36pp | 3.93pp |
| NPM | 3.35% | 0.99pp | 2.62pp |
| EPS | 0.70 | 28.6% | 50.7% |
Steady growth masked by margin compression; recovery hinges on raw material stabilization
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
No prior numeric guidance issued; current trajectory aligns with deferred-clarity framework. Facility timeline on track.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Linc delivered solid double-digit revenue growth (10.8% YoY) and proved execution capability in new categories beyond writing instruments. However, operating margin compressed 390 bps to 7.3% due to geopolitical-driven raw material inflation (190 bps) and elevated sales promotions (200 bps), resulting in PAT declining 38.3% YoY despite top-line strength. Management has flagged near-term RM volatility and deferred clarity on profitability recovery to end-FY27, making the investment case contingent on commodity stabilization and successful West Bengal facility ramp-up.
₹154.1 Cr
Revenue · +10.8% YoY₹5.2 Cr
Reported PAT · −38.3% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Operating income ₹15,412 lakhs with 10.8% YoY growth
METDelivered 154.1 Cr (₹15,412 lakhs) exactly; YoY growth 10.8% confirmed
EBITDA ₹1,131 lakhs at 7.3% margin vs 11.3% prior year
METDelivered OPM 7.3% matches; prior year at 11.3% (390 bps contraction)
393 bps margin contraction split: 190 bps RM cost + 200 bps sales spend
METAttribution adds to 390 bps; accounting is transparent and credible
PAT ₹419 lakhs at 2.7% margin
OVERSTATEDDelivered PAT 5.2 Cr (3.4% margin) vs claimed 4.19 Cr (2.7%). Delivered higher than stated; likely excludes certain items in call.
Raw material mix optimization has cushioned cost impact versus standard SAN/ABS/PP/PC grades
METManagement cites recent 1-1.5 year RM mix development showing lower cost increases; plausible lever but not quantified
Earnings quality
What changed since the last call
RM cost inflation recognition
NewPrior call deferred clarity on RM trajectory. Q2 confirms geopolitical spikes (190 bps impact) with recent December improvements already visible; management now expects stabilization.
Sales promotion intensity sustained
NewNew lever: management explicitly elevated promo spend (200 bps margin drag) to defend market share. Positions growth as share-gaining exercise, not margin-accretive.
West Bengal facility timing reaffirmed
NeutralExpected Q3 commissioning now confirmed Q4 (end Dec/early Jan). No delay; still on original framework. Framed as operational efficiency gain, not as margin expansion inflection.
Premium segment pivot intensified
UpgradeNew Tri-Tonic drinkware brand and expanded Pentonic portfolio explicitly called out as margin-improvement levers alongside RM mix optimization. Strategic shift beyond writing instruments acknowledged.
The Q&A
Light Q&A with 2-3 substantive questions. Shubhankar pressed on margin recovery timeline—management held to 'volatile' messaging, deferring specifics to end-FY27. Girija questioned West Bengal asset turnover and peer margin gap—answered on facility readiness but sidestepped quantified margin targets. Analysts did not push on sales promo sustainability or PAT decline.
Margin recovery trajectory — Shubhankar Ojha, participant
Partial4-6 quarters expected to return to normalized margins if RM prices stabilize. Current situation temporary. Already seeing December improvement. Cannot give exact %, situation volatile; clarity by end-FY27.
Uni-Linc JV product pipeline — Shubhankar Ojha, participant
AnsweredOne ball pen at ₹20 MRP launched, gaining good distribution. 50%+ of JV revenue from exports. 2 more products in pipeline; 3 total products expected over next 3-4 quarters.
West Bengal facility timeline and margin impact — Girija, participant
PartialFactory almost set up; commercial production expected end Dec/early Jan (Q4). Facilities ready by Dec. Focused on operational efficiency from modern infra and scope for future expansion. Not envisaging substantial increase in operations initially; shifting old facility to new with integration and expansion scope.
Internal margin improvement levers — Shubhankar Ojha, participant
AnsweredTwo levers: (1) RM mix optimization developed past 1-1.5 years shows lower cost increases vs standard SAN/ABS/PP/PC grades. (2) Continued focus on premium price-point products (above ₹10) where margins superior to ₹10 price points.
Guidance
No formal FY27 revenue target; deferred to post-Q2 clarity
LowPrior guidance framework: focus on categories beyond writing instruments + JV growth. Q2 delivered 10.8% YoY; trajectory suggests mid-to-high single-digit growth sustainable if macro stable.
EBITDA margins expected to recover toward historical 10%+ range over 4-6 quarters
MediumConditioned on RM price stabilization. Current 7.3% OPM (vs 11.3% prior year) to improve as input costs ease from Q4 onwards.
West Bengal facility capex near completion; Q4 commissioning; no incremental major capex disclosed
HighFacility modern infrastructure replacing old Kolkata plant; scope for future capacity expansion built in. Near-term capex intensity declining post-commissioning.
Risks the call surfaced
Raw material price volatility
HighGeopolitical uncertainties driving polymer price spikes. 190 bps (₹21.5 Cr annualized EBITDA impact) of Q2 margin pressure directly attributable. Unhedged exposure; RM mix optimization provides some insulation but insufficient buffer.
Sales promotion intensity
MediumElevated promotional spending (200 bps margin drag in Q2) deployed to gain market share and support double-digit growth. Unclear if this is temporary growth investment or becomes normalized baseline. If structural, sustainable margin recovery below 10% range.
West Bengal facility execution
MediumFacility critical for long-term margin recovery and export traction (linked to Morris/Korea subsidiary). Commissioning Q4 FY27 (end Dec/early Jan) now reaffirmed. Management does not anticipate substantial output increase initially; facility is replacement + efficiency + expansion headroom. Risk if ramp-up slower than expected or efficiency gains overstated.
Drinkware/new category margin profile
LowTri-Tonic (Tritan-based drinkware) positioned as margin-accretive new category leveraging polymer expertise. Early-stage launch via Stackoo experience centers. Margin profile vs writing instruments not disclosed; execution risk if category scales slower than expected.
JV growth uncertainty
LowUni-Linc JV (Mitsubishi Pencil, Japan) contributing 50%+ of its revenue from exports; early-stage product pipeline (3 products over 3-4 quarters). Turkey and Kenya subsidiaries progressing but without quantified upside. Execution risk if JV product launches miss or market adoption slower.
Management
Score 6/10. Clear on operational metrics and challenges (RM inflation quantified, promo spend acknowledged). Cautious on margin recovery timing; deferred specifics to end-FY27. Balanced in tone; avoids over-assertion but also light on concrete forward-year targets. Revenue guidance framework (growth via categories beyond writing instruments + JVs) being met. West Bengal facility on track (Q4 vs prior Q3 guidance). No major misses vs prior-call framework; conservative realism maintained.
1 · Q4 FY27 (Dec 2026 - Jan 2027)
West Bengal facility commercial production; modern infra to replace old Kolkata plant
2 · Calendar 2027
Uni-Linc JV: 2 new products launch (₹20 MRP ball pen already live; 2 more planned)
3 · Q3-Q4 FY27
Raw material prices expected to ease post-December based on geopolitical announcements; margin recovery tailwind
Management has flagged near-term RM volatility and deferred clarity on profitability recovery to end-FY27, making the investment case contingent on commodity stabilization and successful West Bengal facility ramp-up.